You may be eligible to file a Tylenol Autism ADHD Lawsuit / Acetaminophen Autism ADHD Claim if you or a loved one used Tylenol and/ or Acetaminophen during pregnancy, and your child was subsequently diagnosed with ADHD or Autism Spectrum Disorder.
Over 140,000 Exactech hip, knee and ankle implants have been recalled due to packaging errors that can lead to the breakdown of parts vital to the device’s function.
If you or a loved one suffered injuries from an Exactech implant device, you may be entitled to financial compensation.
You may be eligible to file a Hair Straightener Cancer Lawsuit if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with:
Over one million people, who were present at Camp Lejeune (North Carolina) between 1953 and 1987, may have been exposed to toxic substances in the water.
The Camp Lejeune Contaminated Water Lawsuit can apply to you, a family member, or a loved one who lived at Camp Lejeune (North Carolina) and suffered health effects from the decades of water contamination that occurred.
If you have been exposed to Paraquat and diagnosed with Parkinson’s disease may be eligible to pursue compensation, and entitled to participate in the paraquat lawsuit.
Contact us today to see if you qualify for the Paraquat Parkinson’s Disease Lawsuit!
Our firm is about people. That is our motto and that will always be our reality.
We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.
The THL Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.
Our team is what has made TorHoerman Law a very special place since 2009.
The chemotherapy drug Taxotere, commonly used for breast cancer treatment, has been linked to severe eye injuries, permanent vision loss, and permanent hair loss.
Taxotere lawsuits are being consolidated in the US District Court for the Eastern District of Louisiana, with claims that the manufacturer, Sanofi-Aventis, did not adequately warn about the potential side effects.
Patients who have experienced vision damage, hair loss, or other related medical issues after using Taxotere may be eligible for financial compensation through a lawsuit.
Most Recent Updates:
The Taxotere lawsuit is still in progress with THL lawyers accepting clients nationwide — both parties are currently in a pre-trial negotiation phase.
A 2021 settlement offer was remanded by the U.S. Court of Appeals for the First Circuit, causing settlement delays and a strategy reevaluation.
It's been approximately two (2) years since the settlement process restarted, and the lawsuit is approaching a point where it will either settle or proceed to trial.
Taxotere Lawsuit Update and Overview
The popular chemotherapy drug Taxotere has been linked to severe eye injuries and permanent hair loss.
Taxotere Lawsuits are being filed by breast cancer patients and others who have taken the chemotherapy drug and subsequently developed vision problems such as:
Excessive tearing (epiphora)
Damaged and scarred tear ducts (canalicular stenosis)
Partial vision loss
Permanent vision loss
Severe eye pain
Other eye injuries
Taxotere Lawsuits have also been filed by breast cancer patients who have suffered hair loss due to Taxotere use.
Taxotere Vision Damage Lawsuits are being consolidated into multidistrict litigation (MDL) in the US District Court for the Eastern District of Louisiana.
If you or a loved one used Taxotere and subsequently developed vision damage, hair loss, or other related medical problems, you may be eligible to file a Taxotere Lawsuit and seek financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Taxotere Lawsuit instantly.
Our law firm is committed to helping individuals secure compensation for what they’ve experienced.
Having to undergo cancer treatment is a battle in itself, but having to deal with additional health issues from using a chemotherapy drug can compound the difficulties patients are already dealing with.
Our Taxotere Lawyers are here to help you through this.
Reach out to us for a free consultation or use the chatbot on this page for an instant case evaluation.
The Taxotere Lawsuit is ongoing, and our lawyers are accepting new clients.
The pretrial negotiation period is still ongoing, and signs still show that there is a possibility the Taxotere litigation could be settled by the end of the year.
The Taxotere Eye Injury Litigation currently has 240 pending cases and the Taxotere Products Liability Litigation currently has 10,209 cases.
While the Eye Injury Litigation added 7 cases since last month, the Product Liability Litigation saw a reduction of 201 cases.
If you or a loved one were administered Taxotere and subsequently developed vision loss or other eye injuries, you may be eligible to file a Taxotere Lawsuit.
September 25, 2023
August 8, 2023
The Taxotere lawsuit is ongoing, and THL lawyers are accepting clients from all 50 states.
Currently, the plaintiffs and defendants are in a pre-trial negotiating period, and there have been some minor developments that indicate this litigation could be settled in 2023.
The plaintiffs and settlement committee (a type of committee created to help victims receive proper settlements) came up with a settlement offer in 2021, but the U.S. Court of Appeals for the First Circuit remanded this offer.
This remand resulted in a delay of any settlements being finalized as well as the plaintiffs having to recreate their settlement approach.
It has now been around two years since the settlement process was restarted, and the fate of the litigation remains one that will either soon settle or go to trial.
If you or a loved one suffered eye injury or vision loss after receiving Taxotere, you may be eligible to file a Taxotere Lawsuit and pursue financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Taxotere Lawsuit instantly.
August 8, 2023
July 14, 2023
The Taxotere Eye Injury Lawsuit is ongoing and our Taxotere Lawyers are accepting new clients from all 50 states.
As of July 2023, there have been no settlements made in the Taxotere Lawsuit.
Taxotere Eye Injury Lawsuits are consolidated into multidistrict litigation in the US District Court for the Eastern District of Louisiana.
If you or a loved one suffered eye injury or vision loss after receiving Taxotere, you may be eligible to file a Taxotere Lawsuit and pursue financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Taxotere Lawsuit instantly.
July 14, 2023
Taxotere Lawsuit Overview & Filing Information
Sanofi-Aventis first started facing Taxotere Lawsuits over the potentially permanent hair loss side effects of the drug.
Recently, the potential vision loss side effects of Taxotere have triggered the formation of a Taxotere Eye Injury MDL.
Taxotere Hair Loss Lawsuits and Taxotere Vision Damage Lawsuits are consolidated into different multidistrict litigations.
The Taxotere Hair Loss Lawsuits are consolidated into MDL 2740 and Taxotere Vision Damage Lawsuits are consolidated into MDL 3023.
Taxotere Lawsuits claim that Sanofi-Aventis did not adequately warn patients and warn doctors about potential vision loss or permanent hair loss side effects of the drug.
What is Taxotere?
Taxotere is an intravenous chemotherapy drug belonging to the taxanes class.
Taxotere, produced by Sanofi-Aventis, is the brand name for docetaxel.
First introduced in the late 1990s, Taxotere has been used to treat various cancers, including breast, lung, prostate, and stomach cancer.
Taxotere dosing and frequency of administration may vary depending on the specific cancer being treated and an individual patient’s health status.
Taxotere is typically administered in cycles, with each cycle lasting three weeks.
The cycles are repeated until the prescribed number of cycles is completed or until the patient’s oncologist determines that the treatment should be stopped or modified.
The breast cancer chemotherapy drug Taxotere has been associated with a number of vision-related injuries.
Specifically, it is claimed that Taxotere may secrete into the tear ducts and cause severe damage.
The damage of the tear duct system can lead to excessive tearing and pooling of tears in the eyes.
Doctors have been known to misdiagnose patients with excessive tearing symptoms, not knowing that the lacrimal system is scarred and damaged by the drug.
Vision damage injuries related to Taxotere include, but are not limited to:
Lacrimal duct obstruction
Canalicular stenosis
Punctal stenosis
Swollen eyelids
Excessive tearing (Epiphora)
Blocked tear ducts
Cystoid macular edema (vision loss)
Eye irritation
Blurred vision
Eye floaters
Severe eye pain
Other eye injuries
What Medical Treatments Do Eye Injury Patients Need?
If you begin to suffer eye related side effects of Taxotere, seek immediate treatment from a licensed medical professional.
Permanent damage to your vision is possible with Taxotere side effects.
Patients suffering from vision problems and severe eye pain may need to undergo medical treatments.
These medical treatments may include the placement of stents into nasolacrimal system, such as silicone stents or tubes and permanent jones tubes.
The eye injuries associated with docetaxel (Taxotere) for the treatment of breast cancer have been identified in scientific research for at least two decades.
Scientific studies on lacrimal duct obstruction, excessive tearing, and other eye injuries related to Taxotere cases include:
Journal of Clinical Oncology: The incidence and severity of epiphora and canalicular stenosis appears to be higher in patients receiving weekly docetaxel
Liver damage caused by chemical exposure due to Taxotere treatment.
Hepatotoxicity can cause severe complications and even be life-threatening.
Hepatotoxicity is common in patients with:
Abnormal liver function
Elevated LFT
Fluid Retention
Taxotere’s label warns that the condition may reach severe levels for some patients.
Neutropenia
A low neutrophils (specific white blood cell) count makes patients more likely to contract bacterial infections.
If gone untreated, these bacterial infections can cause severe health conditions and even death.
Patients with neutrophil counts under 1500 cells per 3 cubic millimeters of blood volume are more susceptible to develop neutropenia and are advised against using Taxotere unless necessary.
Doctors are advised to frequently check blood counts for these patients who do use Taxotere.
Hypersensitivity Reactions
Reactions like a rash, low blood pressure, and fatal anaphylaxis.
Patients who received dexamethasone premedication are most susceptible to developing these conditions.
There are people filing Taxotere Lawsuits with the help of experienced attorneys in all 50 states.
Our lawyers are investigating the cancer drug Taxotere and helping injured victims seek compensation for what they’ve gone through.
If you or a loved one suffered vision loss or other related health problems from Taxotere, you may be eligible to file a Taxotere Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Taxotere Lawsuit instantly.
Your Taxotere lawyer will work to build a strong case to prove thatliability for your injuries falls on the manufacturer.
Your Taxotere attorney will work to gather evidence to show liability, assess damages that you incurred from your injuries, file legal documents on your behalf, and work to gain you compensationfor your injuries in the form of a settlement or verdict.
Gathering Evidence for Taxotere Lawsuits
Evidence is extremely important for Taxotere vision damage lawsuits.
Your Taxotere Lawyers will help you gather evidence relevant to your case, but you can begin collecting and retaining evidence on your own.
Evidence for Taxotere Lawsuits may include:
Medical records
Treatment records
Oncology records
Proof that you received Taxotere
Photos and videos of injuries
Any other proof of Taxotere use and subsequent medical problems
Assessing Damages in Taxotere Lawsuits
Damages refer to the total amount of losses related to receiving Taxotere and subsequently developing vision loss or eye injuries.
Your Taxotere Lawyer will help you assess and calculate your damages, using collected evidence to advocate for maximum financial compensation.
Potential damages in a Taxotere Vision Loss Lawsuit may include:
Medical bills
Future medical expenses
Pain and suffering
Emotional damages
Lost quality of life
Lost wages and earning ability
Permanent damage to vision resulting in disability
TorHoerman Law’s team of attorneys and legal support staff are experienced in products liability litigation and have a track record of securing compensation for people harmed at no fault of their own.
We understand how difficult it can be to pursue legal action as you’re dealing with breast cancer treatment and side effects of defective drugs.
Our team is here to fight on your behalf and protect your best interests as you focus on your health.
We operate on a contingency fee basis, so our clients do not ever pay any legal fees until after they have been awarded compensation.
No compensation? No fees.
If you or a loved one developed vision loss or other vision issues after taking Taxotere, you may be eligible to file a Taxotere Lawsuit and secure financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Taxotere Lawsuit instantly.
Across all litigations, TorHoerman Law has secured over $4 billion in negotiated settlements and verdicts.
We aren’t afraid to take on large and influential corporations that injure innocent people.
Reach out to us for more information and speak with our team today.
Taxotere (active ingredient: docetaxel) is manufactured by Sanofi-Aventis and was first approved by the U.S. Food and Drug Administration in May 1996.
Taxotere is used to treat an array of cancers but is most commonly prescribed to treat patients with locally advanced or metastatic breast cancer, which had progressed during anthracycline-based therapy or relapsed during anthracycline-based adjuvant therapy.
The drug is also used as an adjuvant treatment in combination with doxorubicin and cyclophosphamide for individuals with operable node-positive breast cancer.
Taxotere works in stopping the spread of cancerous cells by cutting off the dividing and multiplying of cells in and around a cancerous clump.
Taxotere falls under a specific class of chemotherapy treatments called taxane drugs – made from plant alkaloids.
Of the drugs used to treat breast cancer, Taxotere is the most prescribed drug in its class (taxane) – some sources estimate that 75% of breast cancer patients will receive Taxotere as a form of treatment.
TorHoerman Law is accepting lawsuits for people who have experienced vision damage or permanent vision loss after Taxotere use.
If you or a loved one used Taxotere and subsequently developed vision problems, contact TorHoerman Law to discuss your legal options today, including the possibility of filing a Taxotere Lawsuit.
The Taxotere litigation is ongoing, and Taxotere Lawsuits are being consolidated into multidistrict litigation (MDL).
Multidistrict litigation (MDL) is a special federal legal procedure designed to speed up the process of products liability litigation and ensure consistent decisions across all vision damage lawsuits.
Currently, there is not a Taxotere class action lawsuit.
Rather, Taxotere Lawsuits are consolidated into multidistrict litigation.
Multidistrict litigation is a special federal legal procedure used to consolidate cases of similar fact into one singular district court.
Multidistrict litigation and class action lawsuits are different from each other.
In multidistrict litigation, settlements are distributed to plaintiffs according to the damages and circumstances of each individual case.
In class action lawsuits, settlement compensation would be divided evenly among plaintiffs, regardless of the individual circumstances of each person.
Law firms often use “Taxotere Class Action Lawsuit”, “Taxotere Class Action MDL”, and other terms to describe the multidistrict litigation, but these terms are incorrect.
What are Bellwether Trials in the Taxotere Lawsuit?
Bellwether trials are an important step in multidistrict litigation.
As multidistrict litigation consolidates cases of similar fact into one district court, some MDL plaintiffs are selected to participate in bellwether trials.
A bellwether trial is a small consolidation of lawsuits, taken from a larger group of similar cases, to be tried first.
The bellwether trial is like a practice run to help anticipate the results of future similar cases.
Temporary hair loss is a common side effect of most chemotherapy treatments.
However, most do not cause a complete loss of hair.
Studies find that among all of the side effects associated with chemotherapy, temporary hair loss has the greatest impact on a patient’s quality of life.
Taxotere has been linked to Alopecia, permanent hair loss, in those who take the drug for chemotherapeutic treatment.
Alopecia is a permanent and irreversible hair loss disease that affects all body hair, including:
Eyebrows
Eyelashes
Facial hair
Pubic hair
Multiple studies have found that Taxotere use can result in Alopecia.
Evidence of Alopecia occurring in Taxotere patients includes:
Documents from the Sanofi-funded GEICAM 9805 study – which was presented as evidence in ongoing litigation against Sanofi, that reveal that around 9.2% of patients suffered hair loss that lasted more than a decade.
A 2006 study conducted by the Rock Mountain Cancer Centers, which found that Taxotere caused 6% of women to suffer permanent alopecia.
A 2012 study published in the Annals of Oncology. Of the 20 female participants who received Taxotere, 19 developed permanent hair loss. One participant who was being treated for reoccurring breast cancer had previously undergone chemotherapy with a different drug and had complete hair regrowth, but after using Taxotere, she suffered from permanent hair loss.
Alopecia can severely affect a person’s quality of life, affect body image, and cause depression and distress.
For women who already have to struggle with the burden of breast cancer and chemotherapy, developing Alopecia can be devastating.
For breast cancer survivors, Alopecia is more than a cosmetic effect.
The disease is a constant reminder of the struggle to fight breast cancer.
The 2012 study published in the Annals of Oncology found that women who suffered from Alopecia due to Taxotere suffered “significant impairment” to their quality of life.
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Chicago
Edwardsville
St. Louis
Other Illinois Locations
Other Missouri Locations
